Jabra Enhance Select 500 vs Resound Vivia 9 60S microRIE

The Jabra Enhance Select 500 is a premium behind-the-ear OTC hearing aid priced at $1,995 that earns an A grade with a SoundScore of 4.2/5 in our lab testing. Ranking #13 of 65 OTC hearing aids tested, it places in the top 18% of its category. This 2024 release demonstrates strong speech-in-quiet performance, scoring 4.3/5—a full 1.50 points above the OTC category average. Speech-in-noise scores 1.8/5, which is above the category average by 0.31 points but remains low in absolute terms, reflecting a common challenge across OTC devices. Feedback handling is excellent at 4.6/5, slightly above the already-high category average. Music streaming scores 2.9/5, which is 0.98 points above the category average but only mixed in absolute terms—adequate for casual listening but not audiophile-quality. Own-voice comfort at 2.2/5 falls 0.31 points below the category average, which may be noticeable for users sensitive to how their voice sounds. The Enhance Select 500 supports iPhone and Android streaming, hands-free calling, and uses rechargeable batteries. It's a solid choice for those prioritizing clear speech in quieter environments and reliable feedback control. However, buyers seeking better value might consider the Jabra Enhance Select 300 or Lucid Engage, which offer similar sound performance at lower price points. This model has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.